20:41:21 EDT Mon 29 Apr 2024
Enter Symbol
or Name
USA
CA



T:MDNA - MEDICENNA THERAPEUTICS CORP. J - http://www.medicenna.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
MDNA - T  6.62.30·2.385.02.33-0.16-6.4469.71,1159072.55  2.68  2.302.68  0.21515:59:30Apr 2615 min RT 2¢
TSX - T6.62.30·2.385.02.31-0.18-7.2254.46084042.55  2.68  2.302.68  0.21515:58:5415 min
NEO ATS - U 2.33-0.16-6.434.581632.67  2.67  2.3015:59:3015 min
Alpha - A 2.31-0.18-7.252.2127332.57  2.64  2.3114:03:1115 min
Omega - O 2.52+0.031.22.7642.43  2.52  2.4310:32:0615 min
Pure - P 2.31-0.18-7.22.14182.44  2.53  2.3112:38:2715 min
Chi-X - X 2.32-0.17-6.816.035772.67  2.68  2.3015:55:3015 min
CX2 - H 2.33-0.16-6.487.62091542.61  2.68  2.3115:59:3015 min
CXD - D 2.32-0.17-6.83.17402.49  2.55  2.3214:03:1115 min
TriAct - M 2.4917.138114    Sep 11-2015 min

Recent Trades - Last 10 of 907
Time ETExPriceChangeVolumeBuyerSellerMarkers
16:01:39H2.31-0.183001 Anonymous57 Interactive
15:59:30H2.33-0.1620039 Merrill Lynch1 AnonymousK
15:59:30P2.33-0.162639 Merrill Lynch5 CitadelE
15:59:30U2.33-0.162001 Anonymous2 RBCK
15:59:01M2.34-0.151080 National Bank80 National BankE
15:58:54T2.31-0.181007 TD Sec53 Morgan StanleyK
15:58:33T2.34-0.18471 Anonymous5 Citadel
15:57:59U2.31-0.1820079 CIBC80 National BankK
15:57:59T2.31-0.186007 TD Sec80 National BankK
15:57:38M2.34-0.1547 TD Sec7 TD Sec

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-04-26 09:09C:MDNA2.49News ReleaseMedicenna arranges $20M private placement
2024-04-26 08:09C:MDNA1.95Resume TradingMedicenna Therapeutics resuming at the open
2024-04-26 08:02C:MDNA1.95Halt TradingMedicenna Therapeutics halted at the open
2024-04-09 16:57C:MDNA1.50News ReleaseMedicenna presents MDNA11 clinical data at AACR
2024-04-09 15:21C:MDNA1.70News ReleaseMedicenna presents preclinical data on MDNA113 at AACR
2024-02-14 12:43C:MDNA0.86News ReleaseMedicenna Therapeutics' Dec. 31 cash at $21.8-million
2024-02-14 07:40C:MDNA0.66SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-02-14 07:40C:MDNA0.66SEDAR Interim MD & ASEDAR Interim MD & A
2024-02-13 11:13C:MDNA0.67News ReleaseMedicenna doses first patient in combo Ability-1 study
2024-01-12 17:41C:MDNA0.40News ReleaseMedicenna appoints MNP as auditor
2024-01-09 10:36C:MDNA0.43News ReleaseMedicenna begins enrolment for Ability combo study
2023-12-21 19:39C:MDNA0.41News ReleaseMedicenna has conditional TSX OK for warrant extension
2023-12-19 10:10C:MDNA0.415News ReleaseMedicenna begins trading on OTCQB Venture Market
2023-11-17 11:15C:MDNA0.44News ReleaseMedicenna talks survival benefit in bizaxofusp trial
2023-11-14 14:43C:MDNA0.53News ReleaseMedicenna Therapeutics' Sept. 30 cash at $25.7-million
2023-11-14 08:42C:MDNA0.53SEDAR Interim MD & ASEDAR Interim MD & A
2023-11-14 08:38C:MDNA0.53SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-11-06 10:03C:MDNA0.435News ReleaseMedicenna presents phase 1 MDNA11 study data at SITC
2023-11-03 12:07C:MDNA0.25News ReleaseMedicenna details preclinical MDNA113 data at SITC
2023-10-27 10:05C:MDNA0.335News ReleaseMedicenna receives Nasdaq delisting notice